Today

LuxUrban Hotels Inc. received a delisting determination from Nasdaq due to its low stock bid price and failure to timely file its quarterly report, but plans to appeal by August 30, 2024.

ChampionX Corp is filing a Form 25-NSE to delist its Common Stock from the Nasdaq.

Units are delisting as they separate into individual shares and warrants.

Company filing to remove common stock from exchange; reason unclear.

Ribbon Acquisition Corp. shareholders will vote on amending the trust agreement to adjust monthly extension contributions, impacting the SPAC's deadline.

Advantage Solutions Inc. shareholders will vote on a reverse stock split to potentially regain compliance with listing standards.

SAB Biotherapeutics shareholders will vote on a proposal to issue over 19.99% of outstanding stock and approve an equity plan amendment.

AMC shareholders are voting on proposals to increase authorized shares and enact a 1-for-10 reverse stock split.

Outlook Therapeutics shareholders will vote on proposals to authorize share issuance for warrants, increase authorized shares, and enact a reverse stock split.

Shareholders are voting on extending the deadline to complete a business combination, with implications for the SPAC's future and potential liquidation.

AlphaVest Acquisition Corp. shareholders will vote on proposals to extend the company's deadline to complete a business combination.

Xperi Inc. files supplemental proxy materials related to a contested solicitation and merger discussions, updating prior filings.

Lee Enterprises shareholders will vote on increasing authorized common stock and approving share issuances to maintain Nasdaq listing compliance.

Enanta Pharmaceuticals shareholders will vote on director elections, an equity plan increase, executive compensation, and auditor ratification at the March 11, 2026 annual meeting.

Accolade shareholders will vote on the proposed merger agreement, executive compensation, and a proposal to adjourn the special meeting.

WiSA Technologies shareholders will vote on a reverse stock split to maintain Nasdaq listing and approve significant share issuances.

Kimmeridge is soliciting proxies for a contested election of three directors and several governance changes at SilverBow Resources' annual meeting.

Berry Corp. shareholders will vote on a merger agreement with CRC, advisory compensation, and an adjournment proposal at a special meeting.

Curis shareholders will vote on proposals to increase authorized shares, approve a new incentive plan, and ensure NASDAQ listing compliance.

Aura Biosciences seeks to significantly increase authorized common stock and amend its equity plan, potentially leading to substantial future dilution.